Current advances and outlooks in immunotherapy for pancreatic ductal adenocarcinoma

Pancreatic ductal adenocarcinoma (PDAC) is an incurable cancer resistant to traditional treatments, although a limited number of early-stage patients can undergo radical resection. Immunotherapies for the treatment of haematological malignancies as well as solid tumours have been substantially impro...

Descripción completa

Detalles Bibliográficos
Autores principales: Fan, Jia-qiao, Wang, Meng-Fei, Chen, Hai-Long, Shang, Dong, Das, Jugal K., Song, Jianxun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7023714/
https://www.ncbi.nlm.nih.gov/pubmed/32061257
http://dx.doi.org/10.1186/s12943-020-01151-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7023714/
https://www.ncbi.nlm.nih.gov/pubmed/32061257
http://dx.doi.org/10.1186/s12943-020-01151-3

Ejemplares similares